Medical Marijuana Market Size is Set for Rapid Growth as Innovative Treatments and Rising Awareness Drive Demand by 2032

The Medical Marijuana market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Fenix Innovation Group, Neurotech International, Cymra Life Sciences., GW Pharmaceuticals, Aphria Inc, Columbia Care Inc., UConn Health

[Nevada, United States] - DelveInsight's "Medical Marijuana Market Insights, Epidemiology, and Market Forecast 2032." report offers a detailed examination of Medical Marijuana, covering historical and predicted epidemiology, market trends, and treatment scenarios in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.

To Know in detail about the Medical Marijuana Market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; https://www.delveinsight.com/report-store/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Key Findings from the Medical Marijuana Market Report:
The Medical Marijuana market size is poised for significant growth, with an anticipated Compound Annual Growth Rate (CAGR) during the study period (2019-2032).
In August, 2024: Bazelet Nehushtan LtD. announced that the Safety and Efficacy of Terpene-enriched Oil in ADHD, ADHD is the most frequent neurodevelopmental disorder in childhood. Symptoms often appear in preschool years, and most children (65-80%) continue to experience some ADHD-associated symptoms into adolescence and adulthood.
In July, 2024: Syqe Medical announced that the aim for their study is to evaluate the efficacy of medical aerosol containing 0.25, 0.5, 1.0 milligrams (mg) delta (Δ)9-tetrahydrocannabinol (THC) inhaled three times a day (TID) compared to placebo via the Fixed-dose Syqe Inhaler on pain intensity at Week 15.
In June, 2024: M. H MediCane Ltd. announced that their double-blind, placebo-controlled study is designed to assess the effectiveness of, MediCane's medical oil extracted from MediCane's proprietary strain into GMP-grade olive oil, as an add-on therapy to standard of care (SoC), in reducing agitation and disruptive behaviors in subjects with dementia including probable AD.
In September, 2024: HealthPartners Institute announced that Many patients with Pancreatic Ductal Adenocarcinoma (PDAC) experience burdensome and difficult-to-treat symptoms. The impact of multiple symptoms (called "symptom burden") can negatively affect a patient's quality of life, decrease their ability to tolerate cancer treatments, and lead to worse survival. Current approaches to manage PDAC-associated symptoms often work poorly, with most patients reporting a moderate to severe symptom burden.
As of 2024, over 50 countries have legalized medical marijuana, with around 5-15% of the population in these regions using it for medical purposes.
In the U.S., over 3.6 million people are registered users of medical marijuana, with chronic pain being the most common reason for its use (64% of users).
The most common conditions treated with medical marijuana include chronic pain (30-40%), multiple sclerosis, epilepsy, chemotherapy-induced nausea, HIV/AIDS, anxiety, and PTSD.
Neurological disorders like Parkinson's disease and Alzheimer's are gaining recognition for medical marijuana use due to its neuroprotective effects.
Key Medical Marijuana Companies are as follows: Fenix Innovation Group, Neurotech International, Cymra Life Sciences, GW Pharmaceuticals, Aphria Inc, Columbia Care Inc., UConn Health
Key Medical Marijuana Therapies are as follow: MB-IMP, FEN164, Sativa Oil, Sativex, NTI164, Gabapentin.
Launching multiple stage Medical Marijuana pipeline products is expected to revolutionize market dynamics, further propelling market growth.

Dive into our detailed Medical Marijuana market research report to uncover actionable insights, industry forecasts, and competitive analysis @ https://www.delveinsight.com/sample-request/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Medical Marijuana Overview:
The term medical marijuana refers to using the whole, unprocessed marijuana plant or its basic extracts to treat symptoms ofillness and other conditions. The U.S. Food and Drug Administration (FDA) has not recognized or approved the marijuana plant asmedicine

Medical Marijuana Epidemiology Segmentation:
The Medical Marijuana market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
Medical Marijuana Total Prevalence
Medical Marijuana Prevalent Cases by severity
Medical Marijuana Gender-specific Prevalence
Medical Marijuana Diagnosed Cases of Episodic and Chronic

For more information about Medical Marijuana companies working in the treatment market, visit https://www.delveinsight.com/sample-request/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Medical Marijuana Market Insights
The global medical marijuana market continues to witness robust growth driven by increasing legalization, growing awareness of therapeutic benefits, and expanding research.
The medical marijuana market is projected to reach USD 70 billion by 2030, growing at a CAGR of 17% from 2023 to 2030.
Major growth is being fueled by increasing legalization in regions like Europe, Latin America, and parts of Asia, as well as the rising demand for alternative treatments for chronic conditions.
The most common indications for medical marijuana include chronic pain, cancer-related symptoms, epilepsy, multiple sclerosis, and mental health conditions like anxiety and PTSD

Medical Marijuana Drugs Uptake
Epidiolex continues to dominate the market for the treatment of epilepsy and other seizure disorders, with significant uptake following its FDA approval.
Sativex (nabiximols), used primarily for multiple sclerosis, is experiencing increased adoption in Europe and Canada, where it has regulatory approval.
A growing number of based products are being used for anxiety, PTSD, and sleep disorders, contributing to the market's expansion in the mental health segment.

Dive into our comprehensive market research report to discover in-depth insights, emerging trends, and strategic opportunities @ https://www.delveinsight.com/sample-request/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Medical Marijuana Epidemiology:
The epidemiology section provides insights into historical, current, and forecasted trends in the seven major countries (7MM) from 2019 to 2032. It explores various studies and opinions to recognize the causes of current and forecasted trends. The segmentation includes total prevalence, severity-based prevalence, gender-specific prevalence, and diagnosed cases of episodic and chronic Medical Marijuana.

Seize Market Opportunities with Our Expert Analysis! Our report delivers valuable insights into market dynamics, key players, and emerging trends @ https://www.delveinsight.com/sample-request/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Medical Marijuana Market Drivers:
Expanding Legalization
Growing Acceptance in Healthcare
Increasing Demand for Natural Alternatives
Chronic Disease Prevalence

Medical Marijuana Market Barriers:
Lack of Large-Scale Clinical Data
Stigma and Social Perception
Cost and Accessibility
Competition with Conventional Therapies

Stay Ahead in a Competitive Landscape with Our Exhaustive Market Research Report-Dive Into Detailed Analysis, Key Trends, and Future Projections @ https://www.delveinsight.com/sample-request/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Scope of the Medical Marijuana Market Report:
Study Period: 2019-2032
Coverage: 7MM (The United States, EU5, and Japan)
Key Medical Marijuana Companies: Fenix Innovation Group, Neurotech International, Cymra Life Sciences, GW Pharmaceuticals, Aphria Inc, Columbia Care Inc., UConn Health
Key Medical Marijuana Therapies: , MB-IMP, FEN164, Sativa Oil, Sativex, NTI164, Gabapentin.
Medical Marijuana Therapeutic Assessment: Current marketed and emerging therapies
Medical Marijuana Market Dynamics: Medical Marijuana Market drivers and Medical Marijuana barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Medical Marijuana Unmet Needs: Insights into unmet needs, KOL's views, Analyst's views, Market Access, and Reimbursement.

To access the full report and gain a deeper understanding of Medical Marijuana market outlook, drug uptake, treatment scenario, and epidemiology trends, https://www.delveinsight.com/sample-request/medical-marijuana-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Table of Content:

1. Key Insights
2. Medical Marijuana Executive Summary
3. Competitive Intelligence Analysis for Medical Marijuana
4. Medical Marijuana Market: Overview at a Glance
5. Medical Marijuana: Disease Background and Overview
6. Medical Marijuana Patient Journey
7. Medical Marijuana Epidemiology and Patient Population
8. Medical Marijuana Treatment Algorithm, Current Treatment, and Medical Practices
9. Medical Marijuana Unmet Needs
10. Key Endpoints of Medical Marijuana Treatment
11. Medical Marijuana Marketed Products
12. Emerging Medical Marijuana Therapies
13. Medical Marijuana: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Medical Marijuana Market Outlook
16. Access and Reimbursement Overview of Medical Marijuana
17. KOL Views
18. Medical Marijuana Market Drivers
19. Medical Marijuana Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

List of Top Selling Market Research Reports in 2024

Surgical Energy Generators Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Surgical Sealant Tissue Patch Market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Surgical Stapling Devices Market- https://www.delveinsight.com/report-store/surgical-stapling-devices-market
Vital Sign Monitoring Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Pelvic Organ Prolapse Market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Scoliosis Market- https://www.delveinsight.com/report-store/scoliosis-market
SGLT2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Urinary Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Lymphedema Market- https://www.delveinsight.com/report-store/lymphedema-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Overactive Bladder Market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Facial Lines Market- https://www.delveinsight.com/report-store/facial-lines-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market

About DelveInsight:
DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry.

Contact Information:
Company Name: DelveInsight Business Research LLP
Contact Person: Ram Kapoor
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting

This release was published on openPR.